Many cancers employ the PD-1/PD-L1 axis to avoid immune surveillance by expressing PD-L1 on the tumor cell surface, although the value of PD-L1 expression as a prognostic indicator is variable. The gene discussed is PDCD1; the disease is neoplasm.